Wedbush Cuts Price Target on Insmed (INSM) Following FDA Requests for Additional Tox Studies
Go back to Wedbush Cuts Price Target on Insmed (INSM) Following FDA Requests for Additional Tox Studies| INSMED (NASDAQ: INSM) | Delayed: 123.74 -2.59 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.33 | 52 Week High | $19.30 | |||
| Open | $125.67 | 52 Week Low | $9.02 | |||
| Day High | $126.85 | P/E | N/A | |||
| Day Low | $122.21 | EPS | $-1.69 | |||
| Volume | 1,957,297 | |||||
